Beginning next week Fresenius will begin using Affymax's drug in 100 of their clinics. If successful there are around 1700 more clinics in the United States owned by Fresenius that will be using the drug. This doesn't include other dilysis clinics in the US and world wide. By the way, Fresenius is a world wide organization. This drug has a great chance of being successful because of the once a month application rather than each time a person dialises. (forgive spelling errors).